Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testicular Neoplasms | 11 | 2014 | 13 | 2.410 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 7 | 2014 | 7 | 1.870 |
Why?
|
| Neoplasm Proteins | 7 | 2019 | 228 | 1.820 |
Why?
|
| Germ Cells | 7 | 2019 | 74 | 1.300 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2014 | 734 | 0.590 |
Why?
|
| RNA, Messenger | 5 | 2019 | 1271 | 0.510 |
Why?
|
| Mice | 15 | 2019 | 6644 | 0.460 |
Why?
|
| Genetic Loci | 1 | 2014 | 104 | 0.410 |
Why?
|
| Cytidine Deaminase | 2 | 2013 | 36 | 0.380 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 55 | 0.340 |
Why?
|
| Chromosomes, Mammalian | 2 | 2007 | 18 | 0.330 |
Why?
|
| Genetic Techniques | 1 | 2009 | 14 | 0.310 |
Why?
|
| Animals | 15 | 2019 | 16992 | 0.310 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 165 | 0.300 |
Why?
|
| Models, Animal | 1 | 2009 | 151 | 0.300 |
Why?
|
| X Chromosome | 1 | 2007 | 30 | 0.270 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 300 | 0.260 |
Why?
|
| Y Chromosome | 1 | 2007 | 55 | 0.260 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 561 | 0.260 |
Why?
|
| Testis | 5 | 2014 | 207 | 0.250 |
Why?
|
| Embryonic Development | 1 | 2007 | 83 | 0.240 |
Why?
|
| Transcription Factors | 1 | 2010 | 735 | 0.230 |
Why?
|
| Integrases | 2 | 2019 | 28 | 0.230 |
Why?
|
| Male | 14 | 2019 | 23409 | 0.220 |
Why?
|
| Mutation | 2 | 2005 | 1177 | 0.200 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 665 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2007 | 968 | 0.200 |
Why?
|
| Seminoma | 2 | 2013 | 2 | 0.190 |
Why?
|
| Cell Line | 2 | 2019 | 1410 | 0.180 |
Why?
|
| 3' Untranslated Regions | 3 | 2013 | 82 | 0.180 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2014 | 192 | 0.170 |
Why?
|
| Crosses, Genetic | 2 | 2009 | 48 | 0.150 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 161 | 0.140 |
Why?
|
| Mice, Inbred Strains | 2 | 2007 | 114 | 0.130 |
Why?
|
| DNA, Complementary | 2 | 2008 | 196 | 0.130 |
Why?
|
| Maternal Exposure | 2 | 2014 | 57 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 652 | 0.120 |
Why?
|
| Cell Differentiation | 2 | 2009 | 638 | 0.110 |
Why?
|
| Mice, Congenic | 1 | 2014 | 3 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2013 | 518 | 0.110 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2014 | 21 | 0.110 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 59 | 0.100 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2013 | 1 | 0.100 |
Why?
|
| Ovarian Follicle | 1 | 2014 | 44 | 0.100 |
Why?
|
| Spermatogenesis | 1 | 2014 | 161 | 0.100 |
Why?
|
| Humans | 8 | 2019 | 43102 | 0.090 |
Why?
|
| Fetus | 1 | 2012 | 101 | 0.090 |
Why?
|
| Ribonucleoproteins | 1 | 2011 | 31 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2013 | 456 | 0.090 |
Why?
|
| Mice, Knockout | 2 | 2013 | 1035 | 0.080 |
Why?
|
| Female | 5 | 2019 | 24698 | 0.080 |
Why?
|
| Viscera | 1 | 2010 | 4 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 100 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2010 | 94 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 223 | 0.080 |
Why?
|
| Pregnancy | 3 | 2014 | 1772 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 154 | 0.070 |
Why?
|
| Protein Binding | 2 | 2013 | 1082 | 0.070 |
Why?
|
| Gene Expression | 1 | 2011 | 701 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 83 | 0.070 |
Why?
|
| Pedigree | 1 | 2007 | 94 | 0.070 |
Why?
|
| Embryo Loss | 1 | 2007 | 4 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 157 | 0.060 |
Why?
|
| Sertoli Cells | 1 | 2007 | 43 | 0.060 |
Why?
|
| Antibodies | 1 | 2007 | 144 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2007 | 139 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2007 | 352 | 0.060 |
Why?
|
| Cell Movement | 1 | 2009 | 655 | 0.060 |
Why?
|
| Genetic Complementation Test | 1 | 2005 | 56 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 518 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 138 | 0.060 |
Why?
|
| Genotype | 1 | 2007 | 800 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 1869 | 0.060 |
Why?
|
| Organ Size | 1 | 2005 | 170 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 1596 | 0.060 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 199 | 0.060 |
Why?
|
| Disease Progression | 1 | 2007 | 667 | 0.060 |
Why?
|
| Alleles | 1 | 2005 | 352 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 712 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 515 | 0.050 |
Why?
|
| Cell Survival | 1 | 2007 | 945 | 0.050 |
Why?
|
| Body Weight | 1 | 2005 | 429 | 0.050 |
Why?
|
| Base Sequence | 1 | 2005 | 983 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2009 | 1455 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2007 | 1621 | 0.050 |
Why?
|
| Phenotype | 1 | 2005 | 780 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 704 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 934 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2013 | 2544 | 0.030 |
Why?
|
| Sperm Count | 1 | 2014 | 28 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 12 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 23 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 2013 | 32 | 0.030 |
Why?
|
| Ovary | 1 | 2014 | 113 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 90 | 0.020 |
Why?
|
| Flutamide | 1 | 2012 | 7 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 2012 | 11 | 0.020 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2012 | 20 | 0.020 |
Why?
|
| Androgen Antagonists | 1 | 2012 | 29 | 0.020 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2010 | 3 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2010 | 14 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 2010 | 14 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2010 | 20 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 861 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2010 | 52 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2010 | 49 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 237 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1070 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 760 | 0.020 |
Why?
|
| Proteins | 1 | 2010 | 382 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2010 | 1604 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 1019 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 5080 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 8214 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 12222 | 0.010 |
Why?
|
| Adult | 1 | 2010 | 13872 | 0.010 |
Why?
|